Bausch Health Companies (BHC) Long-Term Deferred Tax (2009 - 2026)

Bausch Health Companies (BHC) has 18 years of Long-Term Deferred Tax data on file, last reported at $1.8 billion in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Deferred Tax fell 6.68% year-over-year to $1.8 billion; the trailing twelve-month figure through Mar 2026 stood at $1.8 billion (down 6.68% YoY), and the FY2025 full-year result was $1.8 billion, down 6.35% from the prior year.
• Long-Term Deferred Tax held at $1.8 billion in Q1 2026, from $1.8 billion in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $2.4 billion in Q3 2022 to a low of $1.8 billion in Q4 2025.
• A 5-year average of $2.1 billion and a median of $2.2 billion in 2023 frame the typical range for Long-Term Deferred Tax.
• Across the five-year window, Long-Term Deferred Tax climbed 6.14% in 2022 and slipped 8.0% in 2025, its largest moves.
• Tracing BHC's Long-Term Deferred Tax over 5 years: stood at $2.2 billion in 2022, then fell by 3.0% to $2.1 billion in 2023, then declined by 6.33% to $2.0 billion in 2024, then slipped by 6.35% to $1.8 billion in 2025, then rose by 0.11% to $1.8 billion in 2026.
• Business Quant data shows BHC's Long-Term Deferred Tax at $1.8 billion in Q1 2026, $1.8 billion in Q4 2025, and $2.1 billion in Q3 2025.